Company Filing History:
Years Active: 2021-2022
Title: The Innovative Contributions of Jenifer Obrigewitch
Introduction
Jenifer Obrigewitch is a prominent inventor based in Boston, MA, known for her significant contributions to the field of biomedical engineering. With a focus on gastrointestinal health, she has developed innovative solutions that address critical health issues. Her work has led to the filing of two patents, showcasing her commitment to advancing medical technology.
Latest Patents
Jenifer's latest patents include an in vitro gastrointestinal model comprising lamina propria-derived cells. This invention features a microfluidic gut-on-chip that mimics the structure and function of specific areas of the gastrointestinal system in vivo. The multicellular, layered microfluidic culture allows for interactions between lamina propria-derived cells, gastrointestinal epithelial cells, and endothelial cells. This system is particularly useful for modeling inflammatory gastrointestinal tissue, such as Crohn's disease and colitis. Furthermore, it enables comparisons between different types of gastrointestinal tissues and disease states, facilitating the identification of cellular factors driving disease and aiding in drug testing for inflammation reduction.
Career Highlights
Jenifer is currently employed at Emulate, Inc., where she continues to push the boundaries of innovation in her field. Her work has garnered attention for its potential to revolutionize the way gastrointestinal disorders are studied and treated.
Collaborations
Throughout her career, Jenifer has collaborated with notable colleagues, including S Jordan Kerns and Michael Salmon. These partnerships have contributed to the advancement of her research and the successful development of her inventions.
Conclusion
Jenifer Obrigewitch's contributions to biomedical engineering, particularly in the area of gastrointestinal health, highlight her role as a leading inventor. Her innovative patents and ongoing work at Emulate, Inc. demonstrate her dedication to improving medical technology and patient outcomes.